Lilly Covid drug, Vatican derivatives, UK mining corruption probe
FT News Briefing
Forhecz Topher
4.4 • 1.3K Ratings
🗓️ 8 October 2020
⏱️ 11 minutes
🧾️ Download transcript
Summary
Eli Lilly, a US drugmaker, has applied for an emergency authorisation of its Covid-19 antibody in the US. According to documents seen by the Financial Times, the Vatican invested donations for the needy in derivatives that bet on the creditworthiness of Hertz. And the FBI picks up the case of two men found dead in a hotel room in Missouri; British prosecutors had seen the men as potential witnesses in a corruption probe into the multibillion-dollar mining house, Eurasian Natural Resources Corporation.
Lilly seeks emergency approval for Covid drug
https://www.ft.com/content/dc7d2abf-1cd2-40db-b040-27b3d9031e8b
Vatican used charity funds to buy Hertz credit derivatives
https://www.ft.com/content/f966e8b4-945a-45d0-8391-a305b3d8f7f5
Silent witnesses: what do three corpses have to do with a corruption case?
https://www.ft.com/content/7dc13ec9-721c-41a7-8423-daeb9a743e9a
Hosted on Acast. See acast.com/privacy for more information.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Good morning from the Financial Times. Today is Thursday October 8th. This is your |
| 0:06.2 | FT news briefing. Eli Lilly has applied for an emergency approval of its |
| 0:11.4 | COVID-19 drug as markets wait for some good news, either |
| 0:15.3 | medical or fiscal. |
| 0:17.3 | Then, according to documents seen by the Financial Times, the Vatican invested donations in derivatives that bet on the credit worthiness of |
| 0:26.3 | Hertz. That's the rental car company. And the FBI picks up the case of two men found dead |
| 0:32.4 | more than five years ago in a hotel room in Missouri, |
| 0:35.8 | we'll look at how this relates to alleged corruption at a British mining company. |
| 0:40.6 | I'm Brendan Greeley, and from Mark Filipino, Here's the news you need to start your day. |
| 0:45.0 | Eli Lilly, the US drugmaker, has applied for an emergency authorization of its COVID-19 antibody in the US. |
| 0:53.0 | This would be among the first treatments available for patients |
| 0:55.8 | with mild to moderate cases of the disease. |
| 0:59.1 | So far, most of the drugs used to treat COVID-19 |
| 1:02.3 | are meant for patients who are already in the hospital. |
| 1:05.6 | An antibody mimics the body's own response and it could be used to treat patients with |
| 1:10.0 | mild or moderate symptoms. |
| 1:12.0 | According to Lily, patients taking a combination of two of its antibodies |
| 1:15.9 | were 85% less likely to end up in the hospital than those who would take in a placebo. |
| 1:22.4 | Lily will be competing with Regeneron, |
| 1:24.8 | which developed the antibody treatment |
| 1:26.4 | that Donald Trump took last week. |
| 1:28.5 | More than 850 patients have taken Lily's treatment. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Forhecz Topher, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Forhecz Topher and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.